Biopharma
Page 1 • 2 itemsGlobal biopharma insights for investors & BD. Track drug development, M&A, and market trends shaping the pharmaceutical landscape.
FDA Breakthrough Therapy TargTex TX202: What You Need to Know
TargTex TX202 is an FDA breakthrough therapy designed to treat advanced melanoma, offering new hope and innovative treatment options for patients.
FDA Approves BriaCell's Bria-IMT: Novel CAR-T Therapy for Advanced Breast Cancer
BriaCell's Bria-IMT has received FDA approval as a novel CAR-T therapy, providing a promising treatment option for patients with advanced breast cancer.